B.PHARM 5TH SEMESTER • BP505T • UNIT-IV

Drugs & Magic Remedies • Animal Ethics • Pharmaceutical Pricing

Drugs and Magic Remedies Act • Prevention of Cruelty to Animals Act • CPCSEA • NPPA • DPCO 2013 • NLEM

Unit-IV of BP505T Pharmaceutical Jurisprudence covers three important areas of pharmaceutical regulation: advertising of drugs and remedies, ethical and legal requirements for the use of animals in experiments, and regulation of pharmaceutical prices in India. The unit includes the Drugs and Magic Remedies (Objectionable Advertisements) Act, the Prevention of Cruelty to Animals Act and regulatory concepts associated with CPCSEA, NPPA, DPCO 2013 and NLEM.

1. Unit-IV at a Glance

Drugs & Magic Remedies Act

Controls objectionable advertisements relating to drugs and certain claims for remedies.

Animal Ethics

Covers prevention of cruelty, institutional animal ethics and regulation of animal experimentation.

Pharmaceutical Pricing

Covers NPPA, DPCO 2013, ceiling price, retail price and NLEM.

2. Drugs and Magic Remedies (Objectionable Advertisements) Act

DRUGS & MAGIC REMEDIES ACT

The Drugs and Magic Remedies (Objectionable Advertisements) Act, 1954 was enacted to control objectionable advertisements relating to drugs and remedies and to prevent misleading or prohibited claims.

2.1 Objectives

To control certain advertisements relating to drugs.
To prohibit advertisements for specified purposes and conditions.
To prevent misleading claims concerning the efficacy of remedies.
To regulate advertisements involving certain so-called magic remedies.

2.2 Important Definitions

Drug: The Act contains a statutory definition of "drug" that covers the specified substances and preparations falling within its scope.

Advertisement: The Act provides a broad statutory concept of advertisement, including notices, circulars, labels and other forms of communication as covered by the legislation.

Magic Remedy: A talisman, mantra, kavacha or other similar article or alleged method possessing miraculous powers for diagnosis, cure, mitigation, treatment or prevention of disease or disorder, as defined by the Act.

2.3 Prohibition of Certain Advertisements

The Act prohibits or restricts advertisements relating to certain diseases, disorders and conditions and advertisements that make prohibited claims regarding drugs or remedies.

Drug / Remedy → Advertisement → Check Statutory Prohibition → Permitted / Prohibited

2.4 Classes of Exempted Advertisements

The legislation recognizes certain classes of advertisements that may be exempted from its prohibitions when the statutory conditions are satisfied.

Government Publications

Certain publications issued or authorized by Government may fall within statutory exemptions.

Scientific / Medical Information

Certain communications may receive statutory treatment depending upon their nature and purpose.

Approved Purposes

Advertisements falling within prescribed statutory exceptions may be exempted.

Exam Tip: When writing exemptions, always refer to the exact wording of the current Act and Rules. Do not assume that every scientific or medical advertisement is automatically exempt.

2.5 Offences and Penalties

Violation of the provisions of the Act may attract penalties as prescribed by the legislation. Students should consult the latest official text for the current penalty provisions.

3. Prevention of Cruelty to Animals Act, 1960

PCA ACT, 1960

The Prevention of Cruelty to Animals Act, 1960 provides a legal framework for prevention of unnecessary pain or suffering to animals and establishes provisions relevant to the use of animals for experimental purposes.

3.1 Objectives

To prevent unnecessary pain or suffering to animals.
To regulate certain activities involving animals.
To provide safeguards for experimental animals.
To establish mechanisms for supervision and ethical oversight.

3.2 Institutional Animal Ethics Committee (IAEC)

The Institutional Animal Ethics Committee (IAEC) is an institutional-level committee concerned with ethical review and oversight of animal experimentation in registered establishments.

Animal Experiment Proposal → IAEC Review → Ethical Assessment → Approval / Modification → Experiment

3.3 CPCSEA

CPCSEA stands for Committee for the Control and Supervision of Experiments on Animals. It is the statutory framework/committee associated with regulation and supervision of animal experimentation under the relevant law and rules.

Key concept: CPCSEA operates at the regulatory level, whereas the IAEC functions at the institutional level for ethical review and oversight of proposed animal experiments.

3.4 CPCSEA – Regulatory Structure

CPCSEA
↓
Registered Establishment → IAEC → Animal Experiment Proposal → Ethical Oversight

3.5 Breeding and Stocking of Animals

Breeding and stocking of laboratory animals are subject to registration and applicable regulatory requirements. Institutions must maintain appropriate facilities, records and animal-care systems.

Housing

Appropriate housing and environmental conditions must be provided.

Nutrition

Animals should receive appropriate food and water according to species-specific requirements.

Veterinary Care

Animal health should be monitored and appropriate veterinary care provided.

Records

Required records relating to animals and experiments must be maintained.

3.6 Performance of Experiments

Experiments involving animals should be scientifically justified and conducted according to applicable ethical and regulatory requirements.

Scientific Need → Protocol → IAEC Review → Authorization → Experiment → Records & Reporting

3.7 Principle of 3Rs

Ethical animal research is commonly explained using the 3Rs principle:

Replacement

Use scientifically acceptable alternatives to animals wherever possible.

Reduction

Use the minimum number of animals necessary to obtain scientifically valid results.

Refinement

Modify procedures to minimize pain, distress and suffering and improve animal welfare.

Ethical Animal Research → Replacement + Reduction + Refinement → Better Animal Welfare

3.8 Transfer and Acquisition of Animals

Acquisition and transfer of laboratory animals must comply with applicable registration, authorization, documentation and transport requirements.

3.9 Records

Registered establishments are required to maintain appropriate records concerning breeding, stocking, acquisition, transfer and experimental use of animals as required under the applicable regulatory framework.

3.10 Power to Suspend or Revoke Registration

The competent authority has statutory powers to take regulatory action, including suspension or revocation of registration, where the prescribed requirements are not complied with.

3.11 Offences and Penalties

The Act and associated rules provide consequences for specified violations. Exact penalties should be checked against the current statutory provisions.

4. National Pharmaceutical Pricing Authority (NPPA)

NPPA

The National Pharmaceutical Pricing Authority (NPPA) is the Government's specialized authority responsible for implementation and enforcement of pharmaceutical price-control measures under the applicable framework, including DPCO.

4.1 Major Functions of NPPA

Implementation of pharmaceutical price-control provisions.
Monitoring prices of medicines under the applicable pricing framework.
Fixation and revision of prices according to statutory provisions.
Monitoring availability of medicines in the market.
Recovery of amounts where applicable under price-control provisions.
Monitoring compliance with applicable pricing requirements.

NPPA → Price Regulation → Price Monitoring → Compliance → Medicine Affordability

5. Drugs Price Control Order (DPCO), 2013

DPCO 2013

The Drugs (Prices Control) Order, 2013 provides the framework for regulation of prices of specified pharmaceutical products, particularly scheduled formulations.

5.1 Objectives of DPCO

To regulate prices of specified medicines.
To control the ceiling prices of scheduled formulations.
To promote availability of essential medicines at reasonable prices.
To establish mechanisms for price fixation and monitoring.

5.2 Important DPCO Terms

Scheduled Formulation

A formulation included in the relevant Schedule of DPCO and therefore subject to applicable price-control provisions.

Ceiling Price

The maximum price determined under DPCO for a scheduled formulation, subject to the applicable provisions.

Retail Price

The price applicable to a formulation as determined under the relevant provisions of DPCO.

Non-Scheduled Formulation

A formulation outside the scheduled formulations is governed by the applicable provisions concerning price monitoring and permissible price increases.

5.3 DPCO Price-Control Flow

NLEM → Scheduled Formulation → Price Calculation → Ceiling Price → Manufacturer Compliance → Market Price Control

5.4 Ceiling Price Concept

Under DPCO 2013, the ceiling price of a scheduled formulation is determined using the prescribed methodology. For educational purposes, the basic concept can be represented as:

Simple conceptual representation:

Average Price to Retailer (PTR)
↓
Prescribed Margin
↓
Ceiling Price

Important: The actual DPCO calculation contains specific statutory definitions, conditions, rounding provisions and other requirements. The exact formula should be learned from the current DPCO text rather than from simplified diagrams alone.

5.5 Retail Price of Formulations

Retail price is the price determined under the applicable DPCO provisions for formulations that are not governed by the ceiling price mechanism in the same manner as scheduled formulations.

5.6 Scheduled vs Non-Scheduled Formulations

Feature	Scheduled Formulation	Non-Scheduled Formulation
Price-control status	Subject to applicable ceiling-price provisions.	Not subject to the same ceiling-price mechanism.
Regulatory monitoring	Price is regulated under DPCO.	Price increase is subject to applicable monitoring provisions.
Key concept	Ceiling Price	Permissible price increase / monitoring

6. National List of Essential Medicines (NLEM)

NLEM

The National List of Essential Medicines (NLEM) identifies medicines considered essential for addressing the priority healthcare needs of the population.

6.1 Importance of NLEM

Supports rational selection of essential medicines.
Helps promote availability of important medicines.
Provides a basis for pharmaceutical policy and price-control frameworks.
Supports public-health priorities.

Priority Health Needs → Essential Medicines → NLEM → Price-Control Framework → Availability & Affordability

7. NPPA – DPCO – NLEM Relationship

NLEM → Scheduled Medicines → DPCO 2013 → Price Regulation → NPPA → Monitoring & Enforcement

8. Unit-IV Important Authorities & Laws

Topic	Main Purpose	Key Terms
Drugs & Magic Remedies Act	Controls objectionable drug advertisements and prohibited claims.	Advertisement, drug, magic remedy, prohibited advertisement
Prevention of Cruelty to Animals Act	Prevention of unnecessary pain or suffering and regulation of animal experimentation.	Animal welfare, IAEC, CPCSEA
NPPA	Implementation and enforcement of pharmaceutical price-control measures.	Price fixation, monitoring, compliance
DPCO 2013	Regulation of prices of specified pharmaceutical formulations.	Ceiling price, retail price, scheduled formulation
NLEM	Identification of essential medicines for priority healthcare needs.	Essential medicines, availability, affordability

9. Unit-IV Master Concept Map

PHARMACEUTICAL JURISPRUDENCE – UNIT IV

Drugs & Magic Remedies Act → Advertisement Control → Public Protection

PCA Act, 1960 → CPCSEA / IAEC → Animal Welfare

NLEM → DPCO 2013 → NPPA → Price Regulation

10. Quick Revision Points

Drugs & Magic Remedies Act
• Controls specified objectionable drug advertisements.
• Restricts certain disease-related claims.
• Regulates advertisements involving magic remedies.

Prevention of Cruelty to Animals Act
• Provides a legal framework for prevention of unnecessary animal suffering.
• Relevant to regulation of experimental animals.
• IAEC provides institutional ethical oversight.
• CPCSEA is associated with regulatory supervision.
• 3Rs: Replacement, Reduction and Refinement.

NPPA / DPCO / NLEM
• NPPA implements and monitors pharmaceutical price-control measures.
• DPCO 2013 provides the price-control framework.
• Scheduled formulations are subject to applicable ceiling-price provisions.
• NLEM identifies essential medicines.

11. Important Examination Questions

Long Answer Questions

Discuss the objectives and salient features of the Drugs and Magic Remedies (Objectionable Advertisements) Act.
Explain the prohibition of certain advertisements under the Drugs and Magic Remedies Act.
Discuss the Prevention of Cruelty to Animals Act and its relevance to animal experimentation.
Explain the role and functions of CPCSEA and IAEC.
Describe CPCSEA guidelines relating to breeding, stocking and experimentation on animals.
Explain the objectives and functions of the National Pharmaceutical Pricing Authority.
Discuss the important provisions of DPCO 2013.
Explain ceiling price and retail price under DPCO 2013.
Discuss the National List of Essential Medicines and its significance.

Short Answer Questions

Define magic remedy.
What is an objectionable advertisement?
Write a note on exempted advertisements.
What is CPCSEA?
What is IAEC?
Explain the 3Rs principle.
Write a note on animal experimentation.
What is NPPA?
What is DPCO 2013?
Define ceiling price.
What is a scheduled formulation?
What is NLEM?
Write the significance of NLEM.

12. Interactive Quick Quiz

Q1. Which organization is associated with regulation and supervision of experiments on animals?

Q2. What does IAEC primarily provide?

Q3. Which principle represents Replacement, Reduction and Refinement?

Q4. Which authority is associated with pharmaceutical price regulation in India?

Q5. DPCO 2013 primarily deals with:

Q6. What does NLEM stand for?

13. One-Minute Memory Map

ADVERTISEMENT CONTROL
Drugs & Magic Remedies Act → Prohibited Advertisements → Public Protection

ANIMAL ETHICS
PCA Act → CPCSEA → IAEC → 3Rs → Ethical Animal Research

PHARMACEUTICAL PRICING
NLEM → DPCO 2013 → Ceiling Price → NPPA → Price Monitoring

Academic & Legal Note: These notes are intended for B.Pharm educational and examination purposes. Pharmaceutical legislation, regulatory authorities, notifications, schedules, price-control provisions and animal research requirements may be amended from time to time. Always refer to the latest official legislation, rules, notifications and regulatory guidance for professional or regulatory use.

Latest Update

BP505T Unit-IV: Drugs & Magic Remedies Act, Animal Ethics, NPPA, DPCO & NLEM | B.Pharm Notes